Top News
Latest News
RESEARCH
27 Feb 2026
Can Big Data Crack the Brain’s Toughest Diseases?MARKET TRENDS
19 Feb 2026
AI Multi-Omics Meets Market Reality CheckRESEARCH
13 Feb 2026
AI and Multi-Omics Join Forces to Rethink Drug DiscoveryINNOVATION
11 Feb 2026
NVIDIA Pushes AI Into the Heart of Drug Discovery
Takeda Turns to AI to Reshape Early Drug Discovery
INVESTMENT
9 Feb 2026
Milestone-based deal with lambic reflects cautious bet on artificial intelligence in pharma research
INSIGHTS
2 Feb 2026
Paige Predict Marks Tempus AI’s Next Leap in Cancer Insight
Tempus AI expands multimodal data and launches Paige Predict to refine cancer diagnostics and drug development
RESEARCH
30 Jan 2026
DeepMind’s AlphaGenome Takes Aim at DNA’s Dark Matter
New AI model improves interpretation of regulatory DNA, helping researchers test disease hypotheses earlier in drug discovery
INNOVATION
23 Jan 2026
Why Lilly and NVIDIA Are Going All In on AI Discovery
Eli Lilly and NVIDIA launch a $1B AI lab to weave artificial intelligence into the earliest stages of drug research
PARTNERSHIPS
20 Jan 2026
Big Pharma Wants Its AI In-House. AstraZeneca Leads
AstraZeneca’s Modella AI buy cements a shift toward owned AI platforms to speed drug discovery and cut research risks
PARTNERSHIPS
13 Jan 2026
Big Pharma’s Billion-Cell Gamble on AI
Illumina’s Billion Cell Atlas teams with Lilly, AstraZeneca, and Merck to reshape how AI learns human biology
INNOVATION
9 Jan 2026
Pharma’s New Lab Partner: Artificial Intelligence
Pharma giants are joining forces on AI tools to speed research, cut costs, and transform R&D culture
SUBSCRIBE FOR UPDATES
By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.